Generation of aggregation prone N-terminally truncated amyloid β peptides by meprin β depends on the sequence

Caroline Schönherr1, Jessica Bien1, Simone Isbert1

  • 1Institute of Pathobiochemistry, University Medical Center of the Johannes Gutenberg University of Mainz, Duesbergweg 6, 55128, Mainz, Germany.

Molecular Neurodegeneration
|February 21, 2016
PubMed
Abstract

Insights

Meprin β cleaves amyloid precursor protein (APP), generating N-terminally truncated Aβ2-x variants independently of BACE-1. These variants aggregate more readily and may contribute to Alzheimer's Disease (AD) pathology.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Molecular Biology

Background:

  • Alzheimer's Disease (AD) involves amyloid precursor protein (APP) processing.
  • Meprin β is a metalloprotease with β-secretase-like activity on APP.
  • Meprin β predominantly generates N-terminally truncated Aβ2-x variants.

Purpose of the Study:

  • Investigate meprin β's role in APP cleavage and Aβ generation.
  • Determine if meprin β contributes to AD-relevant peptide formation.
  • Analyze the properties of meprin β-generated Aβ variants.

Main Methods:

  • Analysis of meprin β knock-out (ko) mice brains.
  • Cellular interaction studies of APP and meprin β.
  • Assessment of Aβ variant aggregation propensity.
  • Studies using Swedish mutant APP (APPswe).

Main Results:

  • Increased sAPPα levels observed in meprin β ko mice.
  • APP cleavage by meprin β occurs before endocytosis.
  • N-terminally truncated Aβ2-40 exhibits higher aggregation than Aβ1-40.
  • Meprin β cannot cleave APPswe to generate truncated Aβ.

Conclusions:

  • Meprin β is implicated in generating N-terminally truncated Aβ2-x peptides.
  • Meprin β functions independently of BACE-1 in APP processing.
  • Meprin β-generated Aβ variants may have distinct aggregation properties relevant to AD.